This article ties to SDG 3. The purpose of this study was to construct and initially evaluate the psychometric properties of the War Anxiety Scale (WAS) and the War Persistent Thinking Scale (WPTS).
Elsevier,
Biodegradability of Conventional Plastics: Opportunities, Challenges, and Misconceptions, Volume 1, 1 January 2022
This chapter aligns with Goal 3: Good health and well-being and Goal 15: Life on land by discussing the issues and consequences of agricultural plastic waste and the product safety associated with aesthetic pollution.
Elsevier,
Biodegradability of Conventional Plastics: Opportunities, Challenges, and Misconceptions, Volume 1, 1 January 2022
This chapter aligns with Goal 3: Good health and well-being and Goal 9: Industry, innovation and infrastructure by discussing the applicability of biological processes for the remediation of plastics as sustainable practice and future implications of biodegradable polymers and composites in the automobile industry.
This scoping review was able to identify 25 tools and methods for assessing health vulnerability and adaptation to climate change, using the Joanna Briggs Institute (JBI) scoping review guidelines.
This article ties to SDG 3. This article studied prenatal maternal stress as a risk factor for offspring mental health challenges.
This study demonstrates the importance of community-based approaches to understand how much MIYCN (Maternal, Infant, and Young Child Nutrition) training and counseling are intertwined, indicating the need for interventions to address both using a multipronged approach that addresses barriers across all levels of the socioecological model, taking the local context into account.
A discussion of progress in treating sognitive impairment for those with schizophrenia.
A trial to try to diagnose children more likely to develop schizophrenia.
Ways to improve cognitive impairment caused by psychosis.
This Article supports Sustainable Development Goal 3 by developing projections of the economic burden of Alzheimer's disease and related dementias, up to 2050. The study predicts that the burden will be $16.9 trillion in 2050, compared with $2.8 trillion in 2019. The authors note that more funding is needed for research into prevention and treatment of Alzheimer's disease.